Oxytocin treatment for amphetamine-induced social impairments

Affiliations

Comment

Dean S Carson. J Neurosci. 2014.

. 2014 Oct 29;34(44):14503-5.

doi: 10.1523/JNEUROSCI.3509-14.2014.

¹ Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 dcarson@stanford.edu.

No abstract available

Comment on

Oxytocin reverses amphetamine-induced deficits in social bonding: evidence for an interaction with nucleus accumbens dopamine.
Young KA, Liu Y, Gobrogge KL, Wang H, Wang Z. Young KA, et al. J Neurosci. 2014 Jun 18;34(25):8499-506. doi: 10.1523/JNEUROSCI.4275-13.2014. J Neurosci. 2014. PMID: 24948805 Free PMC article.

1. Bakermans-Kranenburg MJ, van Ijzendoorn MH. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiatry. 2013;3:e258. doi: 10.1038/tp.2013.34. - DOI - PMC - PubMed
1. Bowen MT, Carson DS, Spiro A, Arnold JC, McGregor IS. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. Plos One. 2011;6:e27237. doi: 10.1371/journal.pone.0027237. - DOI - PMC - PubMed
1. Carson DS, Guastella AJ, Taylor ER, McGregor IS. A brief history of oxytocin and its role in modulating psychostimulant effects. J Psychopharmacol. 2013;27:231–247. doi: 10.1177/0269881112473788. - DOI - PubMed
1. McGinnis JM, Foege WH. Mortality and morbidity attributable to use of addictive substances in the United States. Proc Assoc Am Physicians. 1999;111:109–118. doi: 10.1046/j.1525-1381.1999.09256.x. - DOI - PubMed
1. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci. 2011;12:524–538. doi: 10.1038/nrn3044. - DOI - PubMed